This site uses cookies to improve your experience. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country, we will assume you are from the United States. Select your Cookie Settings or view our Privacy Policy and Terms of Use.
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Used for the proper function of the website
Used for monitoring website traffic and interactions
Cookie Settings
Cookies and similar technologies are used on this website for proper function of the website, for tracking performance analytics and for marketing purposes. We and some of our third-party providers may use cookie data for various purposes. Please review the cookie settings below and choose your preference.
Strictly Necessary: Used for the proper function of the website
Performance/Analytics: Used for monitoring website traffic and interactions
It’s been a hard week for the psychedelics pioneer Rick Doblin. First, the Food and Drug Administration declined to approve the MDMA-assisted therapy for post-traumatic stress disorder developed by Lykos Therapeutics, a company that he founded. The next day, the journal Psychopharmacology retracted three studies on the treatment, in which many authors were associated with Lykos or the nonprofit Doblin founded, the Multidisciplinary Association for Psychedelic Studies (MAPS).
First Opinion is STAT’s platform for interesting, illuminating, and provocative articles about the life sciences writ large, written by biotech insiders, health care workers, researchers, and others. To encourage robust, good-faith discussion about issues raised in First Opinion essays, STAT publishes selected Letters to the Editor received in response to them.
This chart shows the pharmaceutical companies with the most patents in Netherlands. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is desired.
Payroll compliance is a cornerstone of business success, yet for small and midsize businesses, it’s becoming increasingly challenging to navigate the ever-evolving landscape of federal, state, and local regulations. Mistakes can lead to costly penalties and operational disruptions, making it essential to adopt advanced solutions that ensure accuracy and efficiency.
Introduction Twenty years ago, the internet's inception promised a realm of boundless knowledge. In its infancy, slow connections did not deter pioneers eager to explore the web, even though loading a webpage or a YouTube video often took several minutes. For these early adopters, the internet was a gateway to an infinite universe of information. The Rise of Social Media: Connecting People However, the landscape dramatically changed with the rise of social media platforms like Friendster, Facebo
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
52
52
Signup to get articles personalized to your interests!
Pharmacist Digest brings together the best content for pharmacists from the widest variety of industry thought leaders.
Dabigatran etexilate mesylate is the generic ingredient in two branded drugs marketed by Alkem Labs Ltd, Apotex, Hetero Labs Ltd Iii, and Boehringer Ingelheim and, and is included in five NDAs.
Annual Drug Patent Expirations for ADASUVE Adasuve is a drug marketed by Alexza Pharms and is included in one NDA. It is available from one supplier. There are five patents protecting this drug.
Health leaders warn that global response to virus is test case for equity and preparation for future pandemics A failure to show solidarity with African countries at the heart of the mpox outbreak will put the world at risk and harm preparations for future pandemics, health leaders have said. The World Health Organization on Wednesday declared an international public health emergency in the face of rising cases that are spreading beyond the Democratic Republic of the Congo (DRC), where the virus
111
111
Input your email to sign up, or if you already have an account, log in here!
Enter your email address to reset your password. A temporary password will be e‑mailed to you.
We organize all of the trending information in your field so you don't have to. Join 11,000+ users and stay up to date on the latest articles your peers are reading.
You know about us, now we want to get to know you!
Let's personalize your content
Let's get even more personalized
We recognize your account from another site in our network, please click 'Send Email' below to continue with verifying your account and setting a password.
361 
Let's personalize your content